Figure 6
CD4+ T-cell priming defect in miR-142−/− mice. (A) Schematic of the experimental protocol. (B) Flow cytometric analysis of T-cell grafts retrieved from immunized recipient mice indicating proliferated OT-I CD8+ T cells (left) and OT-II CD4+ T cells (right) cells in miR-142+/− (red) and miR-142−/− mice (blue). (C) Quantification of CFSE mean fluorescence intensity (MFI) of proliferated OT-I and OT-II cells. OT-II CFSE MFI WT 14 473 ± 4961 versus CFSE MFI knockout (ko) 31 812 ± 2316, P = .005. Each dot represents an animal. *P < .05 was considered significant using a Student 2-tailed t test. (D) Flow cytometric analysis of splenic CD4+ DCs isolated from miR-142−/− mice and littermate controls for the cell-surface molecule ESAM. Cells were gated on CD11c+ MHCIIhi and CD4+. Each dot represents an animal.

CD4+ T-cell priming defect in miR-142−/− mice. (A) Schematic of the experimental protocol. (B) Flow cytometric analysis of T-cell grafts retrieved from immunized recipient mice indicating proliferated OT-I CD8+ T cells (left) and OT-II CD4+ T cells (right) cells in miR-142+/− (red) and miR-142−/− mice (blue). (C) Quantification of CFSE mean fluorescence intensity (MFI) of proliferated OT-I and OT-II cells. OT-II CFSE MFI WT 14 473 ± 4961 versus CFSE MFI knockout (ko) 31 812 ± 2316, P = .005. Each dot represents an animal. *P < .05 was considered significant using a Student 2-tailed t test. (D) Flow cytometric analysis of splenic CD4+ DCs isolated from miR-142−/− mice and littermate controls for the cell-surface molecule ESAM. Cells were gated on CD11c+ MHCIIhi and CD4+. Each dot represents an animal.

Close Modal

or Create an Account

Close Modal
Close Modal